[Vendor] QST vs QYB on the same compound, same month — both cleared 99.0%
Numbers in the title, numbers in the post. QST vs QYB on the same compound, same month — both cleared 99.0%.
To save the first four comments: 99.0%.
The step schedule question, answered properly, because it comes up weekly.
The label sets a minimum interval of four weeks between increases. That is a floor on how fast you may go, and it exists because tolerability, not efficacy, is what limits most people. There is nothing in the pharmacology that says you must increase at four weeks, or at eight, or ever.
What decides it in practice is whether the effect you want is still there. If appetite is quiet and the trend is going the right way, the dose is doing its job. If both have genuinely gone flat for six weeks or more, that is a conversation worth having with someone who knows your history.
Week 49 was the first time the scale moved after a five-week stall. I changed nothing in that window.
Tell me where this is wrong. That is the useful part of posting it.
- QSQST source pageQingdao Saber Technology Pharmaceutical · Qingdao · 94% here, rank 9 · shop at qingdaosabertechnology.com →
- QYQYB source pageChinaPeptides Co., Ltd. (QYAOBIO) · Shanghai · 93% here, rank 11 · shop at qyaobiopeptides.com →
nofollow and sponsored; nobody here is paid for it.best — the order this archive was captured in
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your food noise pattern is a guess.
dual agonist, so the GIP arm is doing something the sema threads will not tell you about
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.
Same experience with the appetite effect being flatter across the week rather than front-loaded.
Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.
Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.
What step are you on and how long have you been there?
the trials titrated on a calendar, real people titrate on symptoms
What step are you on and how long have you been there?
This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.
This.
crosspost_bot_no is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.
Does constipation follow the day after the shot, or is it spread across the week?
[removed by moderator]
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
Not sure that follows. You went up a step and changed your training in the same fortnight.
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
switching from sema is not a dose conversion, there is no clean equivalence
That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.
zepbound and mounjaro are the same compound with different labels
Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.
pens and vials are the same molecule, the price is the difference
- 1The four-week interval in the label is a minimum. Nothing about the…6 comments in this branch · started by u/ferritin_low